Skip to main content

AnPac Bio-Medical Science Co. Ltd. (ANPC)

NASDAQ: ANPC · IEX Real-Time Price · USD
1.20 -0.09 (-6.98%)
Dec 7, 2021 11:36 AM EST - Market open
Market Cap21.32M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out17.77M
EPS (ttm)-1.20
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume227,564
Open1.30
Previous Close1.29
Day's Range1.15 - 1.41
52-Week Range1.15 - 12.09
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About ANPC

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China. It offers cancer differentiation analysis devices and physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

IndustryBiotechnology
IPO DateJan 30, 2020
Employees86
Stock ExchangeNASDAQ
Ticker SymbolANPC
Full Company Profile

Financial Performance

Financial numbers in millions CNYFinancial Statements

News

AnPac Bio Reports Nine Months Ended September 30, 2021, Same Period Achieved Record Revenue Increased By 55.3% While ...

PHILADELPHIA, Nov. 26, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United S...

1 week ago - GlobeNewsWire

CORRECTION -- Anpac Bio, USA

PHILADELPHIA, Nov. 11, 2021 (GLOBE NEWSWIRE) -- In its press release dated November 9, 2021 entitled “AnPac Bio Announces Pricing of Approximately $2.9 Million Underwritten Public Offering of American D...

3 weeks ago - GlobeNewsWire

AnPac Bio Announces Pricing of Approximately $2.9 Million Underwritten Public Offering of American Depositary Shares

PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC, the “Company”), a biotechnology company with operations in China and the United States focusing on earl...

3 weeks ago - GlobeNewsWire

UPDATE - AnPac Bio Commences Proposed Public Offering of American Depositary Shares

PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC, the “Company”), a biotechnology company with operations in China and the United States focusing on earl...

3 weeks ago - GlobeNewsWire

AnPac Bio Commences Proposed Public Offering of American Depositary Shares

SUNRISE, Fla., Nov. 09, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC, the “Company”), a biotechnology company with operations in China and the United States focusing on ear...

3 weeks ago - GlobeNewsWire

Anpac Bio Invites You to Join Us at the Q4 Virtual Investor Summit

Philadelphia, Pennsylvania--(Newsfile Corp. - November 8, 2021) - Anpac Bio (NASDAQ: ANPC) today announced that Phil Case, Head of Investor Relations | PR will be attending the Q4 Virtual Investor Summi...

4 weeks ago - Newsfile Corp

AnPac Bio Study Shows Strong Correlation between CDA Score and Risk of Cancer and Diseases

Large Population Screening Study Reached Key Milestone with Over 2,000 Confirmed Cases Large Population Screening Study Reached Key Milestone with Over 2,000 Confirmed Cases

2 months ago - GlobeNewsWire

AnPac Bio 2021 First Half Revenue Up 128.5% with Non-GAAP Loss Reduced by 18.3%

PHILADELPHIA, Oct. 01, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United S...

2 months ago - GlobeNewsWire

AnPac Bio Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities Deficiency

PHILADELPHIA, Sept. 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States and...

2 months ago - GlobeNewsWire

BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Ownership Increase In Subsidiary Holding

AnPac Bio-Medical Science (NASDAQ: ANPC) subsidiary AnPac Bio-Medical Science (Lishui) Co. Ltd. has increased its holding in AnPai (Shanghai) Healthcare Management Consultant Co. Ltd.

3 months ago - Benzinga

AnPac Bio Increases Ownership Percentage of its Subsidiary AnPai Healthcare from 20% to 60%

PHILADELPHIA, Sept. 03, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States and...

3 months ago - GlobeNewsWire

AnPac Bio's USA Laboratory Receives Accreditation from the College of American Pathologists

PHILADELPHIA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States and ...

3 months ago - GlobeNewsWire

AnPac Bio Successfully Completes Major PreClinical Study, Files with National Medical Products Administration (NMPA) ...

PHILADELPHIA, Aug. 23, 2021 (GLOBE NEWSWIRE) -- via Investor Wire – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in th...

3 months ago - GlobeNewsWire

AnPac Bio Taps Life Sciences and Diagnostics Veteran as US CEO

PHILADELPHIA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in Ch...

3 months ago - GlobeNewsWire

AnPac Bio and Roche Pharmaceuticals China Entered into Cooperation to Explore Innovative Healthcare and Medical Solut...

PHILADELPHIA, Aug. 05, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United S...

4 months ago - GlobeNewsWire

AnPac Bio Announces Appointment of New Independent Director

Independent Director has Strong Track Record at US Fortune 500 Companies Independent Director has Strong Track Record at US Fortune 500 Companies

4 months ago - GlobeNewsWire

AnPac Bio Began Generating Contract Medical Device R&D Revenue

Also in Final Stages of Partnership/Cooperation Discussions with Major Corporations Also in Final Stages of Partnership/Cooperation Discussions with Major Corporations

4 months ago - GlobeNewsWire

AnPac Bio Stock Gains On Robust Growth In Commercial Testing Volume In Q2

AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) has announced strong growth in test volume in 1H of 2021. The total number of paid customers and testing volume increased almost 110% compared with 1H of ...

4 months ago - Benzinga

AnPac Bio Pre-announces that During First Half 2021, Total Commercial Testing Volume Increased Approximately 110% Ove...

PHILADELPHIA, July 20, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United S...

4 months ago - GlobeNewsWire

AnPac Bio-Medical Stock Moves Higher On First Disease Treatment US Patent

AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) has received its first disease treatment patent by the United States Patent and Trademark Office. The patent covers novel medical devices for both disease...

5 months ago - Benzinga

Best Biotech Penny Stocks to Buy Next Month? 3 For Your Watchlist

Are these biotech penny stocks to watch on your list for July 2021? The post Best Biotech Penny Stocks to Buy Next Month?

Other symbols:PIRSSESN
5 months ago - PennyStocks

AnPac Bio's First Disease Treatment Patent Granted, and Its Cancer Treatment Project Secured Multi-Million Dollar Funds

PHILADELPHIA, June 18, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United S...

5 months ago - GlobeNewsWire

AnPac Bio Reports Strong First Quarter in 2021, with 137.2% Increase in Revenue and Record Number of Commercial Tests...

PHILADELPHIA, May 27, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United St...

6 months ago - GlobeNewsWire

AnPac Bio Shares Jump on Cancer Treatment Technology Related Joint Venture

AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) will establish a joint venture with its founder and chairman, Dr. Chris Chang Yu, and certain other individuals to develop a new cancer treatment technolo...

6 months ago - Benzinga

AnPac Bio Launches Novel Cancer Treatment Technology and Product Joint Venture - Utilizing Findings from 10 Years of ...

SAN JOSE, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (ANPC) (“AnPac Bio,” the “Company” or “we”), a biotechnology company with operations in China and the United States...

6 months ago - GlobeNewsWire